DECEMBER 2022LIFE SCIENCES REVIEW5Analytical Considerations for Combination ProductsJennifer Riter, Sr. Director, Analytical Services, West Pharmaceutical ServicesCLINICAL LABEQUIPMENTCOMPANIES - 2022TOP 10CXO INSIGHTSCIO INSIGHTSAccelerating drug development of novel targeted therapies through histology-agnostic oncology clinical trialsHua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai LabAdvanced Therapies for Patients Suffering from PAHShola Oyewole, CIO, United Therapeutics Corporation [NASDAQ:UTHR]26How Allogeneic Stem Cell Therapies Can Transform Prospects in Inherited Retinal DiseasesGil Carrasquinho, VP Head of Cell Therapy, Santen28Challenges And Opportunities For AI In Drug DiscoveryRobert J. Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Pharmaceuticals and Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Pharmaceuticals2419FEATURED COMPANYMVE Biological Solutions­A Cryoport Company (CYRX: NASDAQ)2218
< Page 4 | Page 6 >